[Anticoagulant therapy of hemostatic disorders in suppurative septic diseases in children].
Experience with the treatment of 50 children enabled the authors to conclude that anticoagulative therapy of the disturbed hemostasis system in children with pyoseptic diseases (syndrome of disseminated intravascular blood coagulation) should be fulfilled as a controlled hypocoagulation at the given therapeutic level. The individual choice of the daily dose of heparin is believed to provide a pronounced clinical effect.
D000293:Adolescent; D001780:Blood Coagulation Tests; D002648:Child; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy* / Q000503:physiopathology; D006487:Hemostasis / Q000187:drug effects; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D018805:Sepsis / Q000150:complications* / Q000503:physiopathology
D006493:Heparin
Antikoaguliantnaia terapiia narusheniĭ gemostaza pri gnoĭno-septicheskikh zabolevaniiakh u deteĭ.